VPIM
Vanguard Personalized Indexing Management’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.2M | Buy |
504,446
+105,453
| +26% | +$2.56M | 0.14% | 124 |
|
2025
Q1 | $10.1M | Buy |
398,993
+51,557
| +15% | +$1.31M | 0.15% | 113 |
|
2024
Q4 | $9.22M | Sell |
347,436
-81,402
| -19% | -$2.16M | 0.14% | 114 |
|
2024
Q3 | $12.4M | Buy |
428,838
+71,292
| +20% | +$2.06M | 0.2% | 81 |
|
2024
Q2 | $9.82M | Buy |
357,546
+47,785
| +15% | +$1.31M | 0.19% | 90 |
|
2024
Q1 | $8.6M | Buy |
309,761
+54,634
| +21% | +$1.52M | 0.18% | 89 |
|
2023
Q4 | $7.35M | Sell |
255,127
-54,090
| -17% | -$1.56M | 0.19% | 86 |
|
2023
Q3 | $10.3M | Sell |
309,217
-20,511
| -6% | -$680K | 0.31% | 46 |
|
2023
Q2 | $12.1M | Buy |
329,728
+1,414
| +0.4% | +$51.9K | 0.37% | 37 |
|
2023
Q1 | $13.4M | Buy |
328,314
+15,868
| +5% | +$647K | 0.47% | 31 |
|
2022
Q4 | $16M | Buy |
312,446
+28,055
| +10% | +$1.44M | 0.66% | 20 |
|
2022
Q3 | $12.4M | Buy |
284,391
+14,124
| +5% | +$618K | 0.56% | 22 |
|
2022
Q2 | $14.2M | Buy |
270,267
+68,866
| +34% | +$3.61M | 0.66% | 18 |
|
2022
Q1 | $10.4M | Buy |
201,401
+36,009
| +22% | +$1.86M | 0.5% | 22 |
|
2021
Q4 | $9.77M | Buy |
165,392
+57,040
| +53% | +$3.37M | 0.58% | 19 |
|
2021
Q3 | $4.66M | Buy |
108,352
+23,325
| +27% | +$1M | 0.42% | 36 |
|
2021
Q2 | $3.33M | Buy |
85,027
+25,455
| +43% | +$997K | 0.35% | 45 |
|
2021
Q1 | $2.16M | Buy |
59,572
+19,762
| +50% | +$716K | 0.33% | 55 |
|
2020
Q4 | $1.47M | Buy |
39,810
+4,894
| +14% | +$180K | 0.32% | 69 |
|
2020
Q3 | $1.28M | Buy |
34,916
+6,599
| +23% | +$242K | 0.36% | 60 |
|
2020
Q2 | $926K | Buy |
28,317
+3,449
| +14% | +$113K | 0.42% | 49 |
|
2020
Q1 | $812K | Buy |
+24,868
| New | +$812K | 0.47% | 53 |
|